Literature DB >> 20595099

Acute leukemia in children with Down syndrome.

Ana C Xavier, Jeffrey W Taub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595099      PMCID： PMC2895024          DOI： 10.3324/haematol.2010.024968

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  34 in total

1.  Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.

Authors:  Christian M Zwaan; Gertjan J L Kaspers; Rob Pieters; Karel Hählen; Gritta E Janka-Schaub; Christina H van Zantwijk; Dieuwke R Huismans; Esther de Vries; Marianne G Rots; Godefridus J Peters; Gerrit Jansen; Ursula Creutzig; Anjo J P Veerman
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.

Authors:  Kelly W Maloney; William L Carroll; Andrew J Carroll; Meenakshi Devidas; Michael J Borowitz; Paul L Martin; Jeanette Pullen; James A Whitlock; Cheryl L Willman; Naomi J Winick; Bruce M Camitta; Stephen P Hunger
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

3.  Prognosis of Down's syndrome with acute leukaemia.

Authors:  G A Levitt; C A Stiller; J M Chessells
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

4.  Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.

Authors:  D K Kalwinsky; S C Raimondi; N J Bunin; D Fairclough; C H Pui; M V Relling; R Ribeiro; G K Rivera
Journal:  Am J Med Genet Suppl       Date:  1990

5.  Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.

Authors:  Y Ravindranath; E Abella; J P Krischer; J Wiley; S Inoue; M Harris; A Chauvenet; C S Alvarado; R Dubowy; A K Ritchey
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

6.  Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  V M Whitehead; M J Vuchich; S J Lauer; D Mahoney; A J Carroll; J J Shuster; D W Esseltine; C Payment; A T Look; J Akabutu
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

7.  Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

Authors:  Alan S Gamis; William G Woods; Todd A Alonzo; Allen Buxton; Beverly Lange; Dorothy R Barnard; Stuart Gold; Franklin O Smith
Journal:  J Clin Oncol       Date:  2003-07-28       Impact factor: 44.544

8.  Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.

Authors:  M Peeters; A Poon
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

9.  The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines.

Authors:  Yubin Ge; Tanya L Jensen; Mark L Stout; Robin M Flatley; Patrick J Grohar; Yaddanapudi Ravindranath; Larry H Matherly; Jeffrey W Taub
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

10.  Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.

Authors:  A H Ragab; A Abdel-Mageed; J J Shuster; L S Frankel; J Pullen; J van Eys; M P Sullivan; J Boyett; M Borowitz; W M Crist
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860
View more
  17 in total

1.  Transient Myeloproliferative Disorder and Down Syndrome: Is there a link?

Authors:  Zenaida S Reyes; Wafa Bashir; Anil Pathare
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

Review 2.  Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.

Authors:  Erik Hefti; Javier G Blanco
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

3.  Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Authors:  Alyssa I Clay-Gilmour; Theresa Hahn; Leah M Preus; Kenan Onel; Andrew Skol; Eric Hungate; Qianqian Zhu; Christopher A Haiman; Daniel O Stram; Loreall Pooler; Xin Sheng; Li Yan; Qian Liu; Qiang Hu; Song Liu; Sebastiano Battaglia; Xiaochun Zhu; AnneMarie W Block; Sheila N J Sait; Ezgi Karaesmen; Abbas Rizvi; Daniel J Weisdorf; Christine B Ambrosone; David Tritchler; Eva Ellinghaus; David Ellinghaus; Martin Stanulla; Jacqueline Clavel; Laurent Orsi; Stephen Spellman; Marcelo C Pasquini; Philip L McCarthy; Lara E Sucheston-Campbell
Journal:  Blood Adv       Date:  2017-09-08

Review 4.  DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.

Authors:  Maria Teresa Esposito; Chi Wai Eric So
Journal:  Chromosoma       Date:  2014-08-12       Impact factor: 4.316

5.  Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.

Authors:  Jennifer Keck-Wherley; Deepak Grover; Sharmistha Bhattacharyya; Xiufen Xu; Derek Holman; Eric D Lombardini; Ranjana Verma; Roopa Biswas; Zygmunt Galdzicki
Journal:  Dev Neurosci       Date:  2011-10-27       Impact factor: 2.984

6.  Opportunities During Early Life for Cancer Prevention: Highlights From a Series of Virtual Meetings With Experts.

Authors:  Dawn M Holman; Natasha D Buchanan
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

7.  Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium.

Authors:  Eleni Th Petridou; Marios K Georgakis; Friederike Erdmann; Xiaomei Ma; Julia E Heck; Anssi Auvinen; Beth A Mueller; Logan G Spector; Eve Roman; Catherine Metayer; Corrado Magnani; Maria S Pombo-de-Oliveira; Sameera Ezzat; Michael E Scheurer; Ana Maria Mora; John D Dockerty; Johnni Hansen; Alice Y Kang; Rong Wang; David R Doody; Eleanor Kane; Waffa M Rashed; Nick Dessypris; Joachim Schüz; Claire Infante-Rivard; Alkistis Skalkidou
Journal:  Eur J Epidemiol       Date:  2018-05-14       Impact factor: 8.082

Review 8.  Genetic causes of cancer predisposition in children and adolescents.

Authors:  Federica Saletta; Luciano Dalla Pozza; Jennifer A Byrne
Journal:  Transl Pediatr       Date:  2015-04

9.  Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.

Authors:  Ina Novak; Ozren Jaksić; Tomislav Kulis; Katarina Batinjan; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

10.  Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia.

Authors:  J C Núñez-Enríquez; A Fajardo-Gutiérrez; E P Buchán-Durán; R Bernáldez-Ríos; A Medina-Sansón; E Jiménez-Hernández; R Amador-Sanchez; J G Peñaloza-Gonzalez; R Paredes-Aguilera; F J Alvarez-Rodriguez; V Bolea-Murga; J de Diego Flores-Chapa; J Flores-Lujano; V C Bekker-Mendez; R Rivera-Luna; M Del Carmen Rodriguez-Zepeda; A Rangel-López; E M Dorantes-Acosta; N Núñez-Villegas; M M Velazquez-Aviña; J R Torres-Nava; N C Reyes-Zepeda; R Cárdenas-Cardos; L V Flores-Villegas; A Martinez-Avalos; F Salamanca-Gómez; C Gorodezky; J Arellano-Galindo; J M Mejía-Aranguré
Journal:  Br J Cancer       Date:  2013-05-21       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.